Hendrik Fischer

Hendrik Fischer is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel peptide compositions. With a total of 4 patents, his work has the potential to impact medical treatments significantly.

Latest Patents

Fischer's latest patents include a pharmaceutical composition comprising a cyclic peptide of the formula X1-GQRETPEGAEAKPWY-X2, which is used for extracorporeal lung treatment. This method focuses on conditioning and improving lung functions extracorporeally by treating a non-ischemic donor lung ex vivo with a cyclized compound of the amino acid sequence of formula X-GQRETPEGAEAKPWY-X. Another notable patent describes a composition that includes a peptide consisting of 7-17 adjacent amino acids, which comprises the hexamer TXEXXE. This peptide is cyclized and does not exhibit TNF receptor binding activity, along with an inhibitor of viral neuraminidase.

Career Highlights

Hendrik Fischer is associated with Apeptico Forschung und Entwicklung GmbH, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to advancing medical science through the development of effective treatments.

Collaborations

Fischer collaborates with esteemed colleagues such as Bernhard Fischer and Rudolf Lucas, contributing to a dynamic research environment that fosters innovation.

Conclusion

Hendrik Fischer's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.